Abstract

Prednisone 10-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2013 - Volume 17, Number 3

Page(s): 236

Download in electronic PDF format for $75
  • Prednisone 10-mg Capsules Page 1

Abstract

A formulation for preparing Prednisone 10-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • prednisone
  • glucocorticoid
  • corticosteroid
  • steroid
  • anti-inflammatory agent
  • immunosuppressive
  • capsule formulation
  • drug shortages

Related Categories

  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2013
Pg. 236
Prednisone 10-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 77
Prednisone 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 497
Prednisone 5 mg/mL ir Oral Mix Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 1999
Pg. 291-294
The Basics of Compounding: Compounding Special Capsules
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 237
Reserpine 0.5-mg Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2001
Pg. 389-390
Capsule and Tablet Disintegrating Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 231
Ethambutol 400-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 232
Isoniazid 300-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 337-339
Stability of Prednisone in Oral Mix Suspending Vehicle
Author(s): Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
May/Jun 2016
Pg. 209-214
Basics of Compounding: Special Capsules
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 234
Mercaptopurine 75-mg Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2001
Pg. 401-405
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Jul/Aug 2023
Pg. 320-321
Cyclosporine Topical Gel Formulation
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 230
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Author(s): Allen Loyd V Jr